Cargando…
Impact of ATP synthase/coupling factor 6 in hypoxic pulmonary arterial hypertension: An experimental rat model
BACKGROUND/AIM: Hypoxia-induced pulmonary arterial hypertension (PAH) is characterized by prostacyclin (PGI(2)) disorder, which manifests in the same manner as in monocrotaline (MCT)-induced PAH. Endogenous PGI(2) inhibitor coupling factor 6 (CF6) is involved in MCT-induced PAH. This study aimed to...
Autores principales: | LI, Nannan, SHI, Yugen, YIN, Jie, SUN, Li, ZHANG, Qingshan, BAO, Shuai, ZHANG, Juan, LI, Youlei, WANG, Miaomiao, ZHANG, Yanwei, XUE, Mei, QI, Lei, LI, Yan, YAN, Suhua, LI, Xiaolu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific and Technological Research Council of Turkey (TUBITAK)
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395693/ https://www.ncbi.nlm.nih.gov/pubmed/36422496 http://dx.doi.org/10.55730/1300-0144.5485 |
Ejemplares similares
-
Role of P2X(7)R in the development and progression of pulmonary hypertension
por: Yin, Jie, et al.
Publicado: (2017) -
Lung-specific RNA interference of coupling factor 6, a novel peptide, attenuates pulmonary arterial hypertension in rats
por: Yin, Jie, et al.
Publicado: (2016) -
Semaphorin 3A attenuates cardiac autonomic disorders and reduces inducible ventricular arrhythmias in rats with experimental myocardial infarction
por: Hu, Hesheng, et al.
Publicado: (2016) -
Edaravone alleviates lung damage in mice with hypoxic pulmonary hypertension by increasing nitric oxide synthase 3 expression
por: Zheng, Wan, et al.
Publicado: (2023) -
F-Type ATP Synthase Assembly Factors Atp11 and Atp12 in Arabidopsis
por: Duan, Zhikun, et al.
Publicado: (2020)